EU vs US Clinical Data Conundrum: Careful Assessment Needed With Current State Of Flux
This article was originally published in Clinica
Executive Summary
Where are companies best advised to obtain their clinical data, the EU or the US, and why? These are questions Amanda Maxwell put to Patrick Biggins and Michelle McDonough of US consultancy Musculoskeletal Clinical Regulatory Advisers